J Genet Med.  2022 Dec;19(2):49-56. 10.5734/JGM.2022.19.2.49.

Mitophagy stimulation as a novel strategy for the treatment of mitochondrial diseases

• Lee KM
• Yun J

• KMID: 2537686
• DOI: http://doi.org/10.5734/JGM.2022.19.2.49

Abstract

Mitophagy, the selective degradation of damaged or surplus mitochondria using core autophagy machinery, plays an essential role in maintaining cellular mitochondrial function. Impaired mitophagy is closely linked to various human diseases, including neurodegenerative diseases, cardiovascular diseases, cancers and kidney disease. Defective mitophagy induces the accumulation of damaged mitochondria and thereby results in a decline in cellular survival and tissue function. Accordingly, enhancement of mitophagy has been proposed as a novel strategy for the treatment of human diseases closely linked to mitochondrial dysfunction. Recent studies showing that the stimulation of mitophagy has a therapeutic effect on several disease models highlight the possibility of disease treatment using mitophagy. The development of mitophagy inducers with toxicity and the identification of molecular mechanisms will enable the clinical application of mitophagy-based treatments.

Keyword

Mitophagy; Mitochondrial disease; Drug development.